Product image of Lansoprazol Ratiopharm (Lansoprazole) supplied by GNH India

Lansoprazol Ratiopharm

Active Ingredient:
Lansoprazole
Origin:
EU

Lansoprazol Ratiopharm (Lansoprazole)

Lansoprazole, the active ingredient in Lansoprazol Ratiopharm, is a proton pump inhibitor presented as oral tablets for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcers and related disorders.

GNH India supplies Lansoprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lansoprazol Ratiopharm is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions.

  • Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation.
  • Erosive esophagitis: accelerates mucosal healing and reduces recurrence.
  • Peptic ulcer disease: promotes ulcer healing and prevents recurrence.
  • Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
  • Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients on chronic NSAID therapy.

How It Works

  • Lansoprazole irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory canaliculi of gastric parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increased gastric pH and facilitating mucosal healing in acid‑related disorders.

Side Effects

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: watery stools, usually transient.
  • Abdominal pain: discomfort or cramping.
  • Nausea: feeling of unease or urge to vomit.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
  • Severe allergic reactions: anaphylaxis, angioedema, or rash.
  • Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions.
  • Hepatic enzyme elevation: increased ALT/AST levels.
  • Hypomagnesemia: low serum magnesium with prolonged use.
  • Interstitial nephritis: kidney inflammation presenting with renal dysfunction.

Precautions & Warnings

Before initiating Lansoprazol Ratiopharm, consider the following precautions.

  • Renal function assessment: adjust use in patients with severe renal impairment.
  • Magnesium monitoring: check serum magnesium during long‑term therapy.
  • Elderly patients: use cautiously as they may be more susceptible to adverse effects.
  • Discontinuation: avoid abrupt cessation after prolonged use to prevent rebound acid hypersecretion.
  • Concomitant medications: review other drugs that may interact with acid suppression.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Lansoprazol Ratiopharm may interact with several medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Clarithromycin: may increase lansoprazole plasma concentrations.
  • Ketoconazole: reduced absorption of ketoconazole when gastric pH is increased.
  • Atazanavir: decreased atazanavir exposure leading to subtherapeutic levels.

Moderate Interactions (Monitor Closely)

  • Digoxin: potential increase in digoxin levels; monitor serum concentrations.
  • Methotrexate: reduced clearance may raise methotrexate toxicity; monitor renal function and drug levels.

Frequently Asked Questions

Lansoprazol Ratiopharm is prescribed to manage acid‑related gastrointestinal disorders such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, Helicobacter pylori eradication regimens, Zollinger‑Ellison syndrome, and to prevent ulcers caused by long‑term NSAID use.

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. By irreversibly inhibiting this pump, it stops the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity.

The specific dose and treatment duration of Lansoprazol Ratiopharm are determined by the prescribing clinician based on the patient’s diagnosis, severity of disease, and individual response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazol Ratiopharm belongs to the same class as omeprazole, esomeprazole and pantoprazole. All PPIs share a similar mechanism of inhibiting the gastric proton pump, but differences in pharmacokinetics, drug‑interaction profiles and individual patient response may influence the choice of agent.

Lansoprazol Ratiopharm should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight to maintain product stability throughout its shelf life.

The medication is taken orally, usually as a tablet, with a glass of water. It is generally recommended to swallow the tablet whole, preferably before a meal, unless the prescriber provides alternative instructions.

Serious risks, though rare, include Clostridioides difficile‑associated diarrhea, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, liver enzyme elevations, low magnesium levels, and interstitial nephritis. Patients should seek immediate medical attention if they experience any of these symptoms.

Patients with known hypersensitivity to lansoprazole or any component of the formulation should avoid the drug. Caution is also advised for individuals with severe liver disease, those on medications that have major interactions, and patients who are pregnant or breastfeeding without a clear medical indication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lansoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT